16 min read
Keypoint Newsletter: Welcome to the Fellows Class of 2023
By Heather Gerhart
Keystone Symposia is pleased to introduce the Keystone Symposia Fellows Class of 2023! This year we...
Dr. David Alagpulinsa received a bachelor’s degree in Pharmacy from Kwame Nkrumah University of Science & Technology, Kumasi, Ghana, and a PhD in Interdisciplinary Biomedical Sciences from the University of Arkansas for Medical Sciences. He completed his postdoctoral training at the Massachusetts General Hospital (MGH) and Harvard Medical School in Boston, where he is currently a faculty Instructor in Medicine and Investigation. His research interests include genomic instability, hematopoiesis, autoimmunity, and cardiovascular disease.
Dr. Alagpulinsa was the MGH nominee for the American Diabetes Association Pathway to Stop Diabetes Initiator Award and was recently awarded the JDRF Diversifying Diabetes Research Talent in Academia Grant Award. His current research focuses on the role of bone marrow hematopoiesis in type 1 diabetes and cardiovascular disease. Dr. Alagpulinsa is a past recipient of the Keystone Symposia Global Health Travel Award.
Research Area(s):
Metabolic DiseaseResearch Keywords:
Mentor: Arturo Zychlinsky, PhD
Dec 8, 2022 by Keystone Symposia
By Heather Gerhart
Keystone Symposia is pleased to introduce the Keystone Symposia Fellows Class of 2023! This year we...
Mar 29, 2022 by Shannon Weiman
Keystone Symposia was founded on the idea of bringing academic and industry scientists together to accelerate...